Collaboration and License Agreements - Contract Liabilities - Additional Information (Details) - USD ($) $ in Thousands |
6 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||||
| Deferred revenue | $ 54,690 | $ 28,467 | $ 32,291 | $ 94,063 |
| ModernaTX, Inc | ||||
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||||
| Deferred revenue | 9,300 | |||
| Regeneron Pharmaceuticals, Inc | ||||
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||||
| Deferred revenue | $ 45,400 | |||
| Deferred Revenue Recognition Maturity Year | 2030 |